PROKIDNEY CORP (PROK) Stock Balance Sheet
NASDAQ:PROK - Nasdaq - KYG7S53R1049 - Common Stock - Currency: USD
| MRQ (2024-9-30) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash | N/A | N/A | N/A | 440.49K | N/A | |||
| Cash Equivalents | 108.09M | 60.65M | 490.30M | 20.60M | 4.60M | |||
| Marketable Securities | 298.72M | 302.30M | N/A | N/A | N/A | |||
| Receivables | 5.10M | 1.38M | N/A | N/A | N/A | |||
| Other Current Assets | 18.31M | 9.82M | 14.50M | 6.70M | 1.10M | |||
| Total Current Assets | 430.23M | 374.15M | 504.70M | 27.30M | 5.60M | |||
| Non-Current Assets | ||||||||
| PPE Net | 44.57M | 46.41M | 13.10M | 12.60M | 10.50M | |||
| Investments And Advances | N/A | N/A | N/A | 250.01M | N/A | |||
| Intangibles | N/A | 0.00 | 200.00K | 400.00K | 600.00K | |||
| Other Non-Current Assets | N/A | N/A | N/A | 247.50K | N/A | |||
| Total Non-Current Assets | 44.57M | 46.41M | 13.30M | 13.00M | 11.10M | |||
| TOTAL ASSETS | 474.79M | 420.55M | 518.00M | 40.30M | 16.70M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | 35.00K | 52.00K | 0.00 | 0.00 | 0.00 | |||
| Accrued Expenses | 22.30M | 18.42M | 7.80M | 3.20M | 1.80M | |||
| Accounts Payable | 2.85M | 5.10M | 3.00M | 2.80M | 800.00K | |||
| Other Current Liabilities | 0.00 | 1.47M | N/A | 6.20M | 2.90M | |||
| Total Current Liabilities | 25.18M | 25.04M | 10.90M | 12.30M | 5.50M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 82.00K | 104.00K | 0.00 | 100.00K | 100.00K | |||
| Other Non-Current Liabilities | 6.06M | 4.07M | 2.10M | 1.00M | 1.20M | |||
| Total Non-Current Liabilities | 1.43B | 1.50B | 1.60B | 1.10M | 1.30M | |||
| TOTAL LIABILITIES | 1.45B | 1.52B | 1.61B | 13.40M | 6.80M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -1.18B | -1.14B | -1.10B | -161.50M | -106.40M | |||
| Additional Paid In Capital | 199.51M | 36.11M | 7.50M | N/A | N/A | |||
| Minority Interest | 1.42B | 1.49B | 1.60B | N/A | N/A | |||
| Common Shares | 29.00K | 23.00K | 0.00 | 188.40M | 116.20M | |||
| Other Shareholders' Equity | 321.00K | 130.00K | N/A | N/A | N/A | |||
| Shares Outstanding | 291.66M | 228.18M | 61.50M | 61.50M | 61.50M | |||
| Tangible Book Value per Share | -3.36 | -4.84 | -17.83 | 0.43 | 0.15 | |||
| Total Shareholders' Equity | -979.71M | -1.10B | -1.10B | 26.90M | 9.90M | |||
| TOTAL LIABILITIES AND EQUITY | 474.79M | 420.55M | 518.00M | 40.30M | 16.70M | |||
| Statistics | ||||||||
| Debt/Equity | -0.00 | -0.00 | N/A | 0.00 | 0.01 | |||
| Current Ratio | 17.09 | 14.94 | 46.30 | 2.22 | 1.02 | |||
| Return On Assets (ROA) | -9.61% | -8.43% | -20.86% | -136.85% | -160.18% | |||
| Return On Equity (ROE) | N/A | N/A | N/A | -205.02% | -270.20% | |||
All data in USD , ROIC based on taxRate of 0.21